Preclinical Research Dosing Models Animal model studies have explored GHK-Cu at the following ranges: Topical (in vitro/ex vivo): 10100 M concentrations in cell culture media Subcutaneous (rodent models): 15 mg/kg body weight, administered 12x daily Wound healing models: Local application at 110 g/wound site Reconstitution for Research GHK-Cu is typically supplied as a lyophilized powder
If youre feeling tired, run down, or have a diagnosed deficiency, an injection may be right for you
doi: 10.1530/JOE-13-0477 64 ZhaoYXiaoXFrankSJLinHYXiaY
Cloudiness results from peptide aggregation driven by unstable copper ion coordination when bacteriostatic water is too warm (above 8C), when the lyophilised peptide is older than 6 months, or when the vial is shaken instead of gently swirled
Garzotto et al., 2008)
If youre experiencing fatigue, slowed recovery, low energy, or want to enhance your overall wellness and performance, peptide therapy may be an excellent option
